118 research outputs found
Interview with Ruba Salih, by Nadeem Karkabi and Sonia Boulos
No full textOn the occasion of publishing a special issue of Palestine/
Israel Review (PIR) on the decolonization of the city of Haifa, PIR interviewed Ruba Salih, a professor of anthropology at the Department of
Arts, University of Bologna. Salih’s research focuses on transnational
migration and diasporas across Europe, the Middle East, and North
Africa; Islam and gender; the Palestine question and refugees; and
trauma and conflict in the Middle East. She is the author of numerous academic works, including the book Gender in Transnationalism:
Home, Longing and Belonging among Moroccan (Routledge, 2003), and
the article “Bodies That Walk, Bodies That Talk, Bodies That Love: Palestinian Women Refugees, Affectivity, and the Politics of the Ordinary” (Antipode, 2017). Currently, she is working on a book on waiting and the politics of return among Palestinian refugees (Cambridge University Press). Ruba herself is the daughter of a Palestinian refugee from
Haifa, and her mother was born in Yafa/Jaffa. PIR held an interview
with her to talk about her work and her own experience of refuge as a
descendant of Palestinian refugees from Haifa. Nadeem Karkabi and
Sonia Boulos conducted the interview for PIR
Synthese d'olefines allyliques fluorees et leurs applications dans les tensioactifs et les silicones fluores
No full textSIGLECNRS T Bordereau / INIST-CNRS - Institut de l'Information Scientifique et TechniqueFRFranc
Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast
No full text[No abstract available]Esposito NN, 2007, MODERN PATHOL, V20, P130, DOI 10.1038-modpathol.3800721; Qureshi HS, 2006, AM J CLIN PATHOL, V125, P377, DOI 10.1309-WMX7DRWTFVQP2LOT; Rakha EA, 2005, HISTOPATHOLOGY, V46, P685, DOI 10.1111-j.1365-2559.2005.02156.x; Rakha EA, 2010, AM J SURG PATHOL, V34, P1472, DOI 10.1097-PAS.0b013e3181f01916; Tavassoli FA, 2003, WHO CLASS TUM PATH G, P23; Wheeler DT, 2004, AM J SURG PATHOL, V28, P1587, DOI 10.1097-00000478-200412000-0000611
Nerve sheath tumor with degenerative atypia and multivacuolated lipoblasts
No full textLipoblastic nerve sheath tumor is a recently described benign soft tissue tumor consisting of lipoblasts in a neural-schwannian background. The 6 reported cases have exclusively comprised signet ring lipoblasts and showed no cellular atypia. The authors describe the first lipoblastic nerve sheath tumor to harbor multivacuolated lipoblasts and degenerative atypia, underscoring its important differential diagnosis with well-differentiated liposarcoma. The purpose of this report is to expand the morphologic spectrum of this unusual neoplasm, and reemphasize the potential of benign nonadipocytic tumors to harbor multivacuolated lipoblasts and mimic liposarcoma. © 2012 The Author(s).Ayad T, 2007, EUR ARCH OTO-RHINO-L, V264, P93, DOI 10.1007-s00405-006-0119-6; Ceballos KM, 1999, ARCH PATHOL LAB MED, V123, P941; Chen E, 2010, AM J SURG PATHOL, V34, P707, DOI 10.1097-PAS.0b013e3181d74bdb; Coffin CM, 2009, AM J SURG PATHOL, V33, P1705, DOI 10.1097-PAS.0b013e3181b76462; Dei Tos Angelo P., 1994, American Journal of Surgical Pathology, V18, P913, DOI 10.1097-00000478-199409000-00006; Fukunaga M, 1998, PATHOL INT, V48, P562, DOI 10.1111-j.1440-1827.1998.tb03950.x; Hornick JL, 2004, AM J SURG PATHOL, V28, P1257, DOI 10.1097-01.pas.0000135524.73447.4a; Khalifa MA, 2000, AM J CLIN PATHOL, V114, P123; Lae ME, 2002, HISTOPATHOLOGY, V40, P505, DOI 10.1046-j.1365-2559.2002.01409.x; Mentzel T, 2010, MODERN PATHOL, V23, P729, DOI 10.1038-modpathol.2010.66; Plaza JA, 2006, AM J SURG PATHOL, V30, P337; Vecchio G M, 2010, Pathologica, V102, P108; Weiss SW, 2008, ENZINGER WEISSS SOFT; Weiss S W, 1996, Monogr Pathol, V38, P2070
Nouveau matériau biodégradable et absorbeur d'oxygène à base d'amidon et de polycaprolactone. Evolution des propriétés en fonction de l'humidité
No full textLes propriétés d une matrice à base d amidon thermoplastique (TPS) ont été caractérisées, et notamment leurs variations avec l humidité. Le TPS a été mélangé à du polycaprolactone (PCL) un polyester hydrophobe, pour limiter la sensibilité à l humidité du matériau. Un PCL de faible masse molaire (37000 g/mol, PCL37) et une vitesse d'extrusion faible favorisent la migration du PCL en surface du film mais le matériau est très hétérogène. Au contraire, avec un PCL de masse molaire plus élevée (50000 g/mol, PCL50) et un cisaillement plus fort, la répartition des deux phases du mélange est fine et homogène. Une inversion de continuité de phase est observée vers 50% de PCL50. Des interactions de type hydrogène entre le PCL et l'amidon ont été mises en évidence. L ajout de PCL50 limite les variations de la structure cristalline de l amidon avec l humidité ainsi que la sorption d eau de la phase TPS pour les activités de l eau élevées (> 0.8). La résistance mécanique des films augmente proportionnellement au taux de PCL. Leur déformation à la rupture est améliorée grâce à l'étirage uniaxial en sortie d extrudeuse. Une fonctionnalité d'absorption d'oxygène est donnée au matériau par l'ajout de particules actives. Le film contribuera ainsi à allonger la durée de vie des aliments dans le cas d une utilisation comme emballage alimentaire. Le film contenant 15% d'acide ascorbique et 1.5% de fer absorbe la quantité d oxygène voulue en 15 jours à 85% d humidité relative. La résistance mécanique de ce film est faible mais l'addition de 20% de PCL50 permet de compenser cet inconvénient malgré une absorption d'oxygène ralentie.The properties of a thermoplastic starch matrix (TPS) have been characterized, in particular their variations with humidity. TPS has been mixed with Polycaprolactone (PCL), an hydrophobic polyester, in order to limit the material sensibility to humidity. A PCL of low molar mass (37000 g/mol, PCL37) and a low extrusion speed favor the PCL migration on the film surface but the material is heterogeneous. On the contrary, with a PCL of higher molar mass (50000 g/mol, PCL50) and a higher shearing rate, the repartition of the blend both phases is fine and homogeneous. An inversion of phase continuity is observed near 50% of PCL50. Interactions as hydrogen bonds between PCL and starch have been highlighted. PCL50 addition limits starch crystalline structure variations with humidity as well as water sorption of TPS phase on high water activities (>0.8). Films mechanical resistance increases in proportion to PCL rate. Their elongation at break is improved thanks to uniaxially orientation at the end of the extruder. An oxygen scavenging capacity is given to these materials by active agent addition. The film will so contribute to prolong the shelf-life of food in the case of a use as food packaging. The film containing 15% of ascorbic acid and 1.5% of iron absorbs the expected quantity of oxygen in 15 days at 85% relative humidity. This film mechanical resistance is low but the addition of 20% of PCL50 allows compensating this drawback in spite of slower oxygen absorption.ROUEN-BU Sciences Madrillet (765752101) / SudocSudocFranceF
UA-R-GC-1914-01-01-1965-12-03_Page-008
No full textf
I •
e
I.
..
·8-
BACHELOR OF ARTS
F~ the Undergraduate Faculty
, of Arts & Sciences
ARABI~ StuDIES
Ageya Rams Is Haks imos
Maurice Boulos Sallb
ENGLISH LITERATURE
Anna N I k I ta Kondou
ECONOMICS-POLITICAL SCIENCE
Ahmed Sakaf Mohamad Albar
(In absentla)+
Dimitri Zenon Voyladzis
*OJ ehane E I Abd
Esmat Ahmed £1 Banna
Fari da Abde I Ham I d Gadou
(i n absent la) +
Fawzia Mohamad EI Tayeb
Fecal Nazir AI Farra
(I n absent la) +
Hash 1m Kam i I Madan I
(in absentla)+
Isabelle Maria Riso-Levl
Laila Fouad Barsoum
SOCIOLOGY-ANTHROPOLOGY
*Alan James McTeague
(In absentia)
Fatheya Ahmed TiJani
Fatma Youssef EI Kholy
I rene Sacroug
Layla Shafik Iskander
MASTER OF SCIENCE
* Panayotls Zaronis
*It Soraya Mohamed E I Torky
Kadlha Mohamad Sherif+ -
Mahmoud Sol iman Mahmoud
;- Haria Magda lena Dagnan
Mohamad Faris Gibriel
Mukh lis Jama J Hanmour i
**Nawa I Abde I Monelm E I Tc: .
Tatawi
(In absentia)+
Saad Asian Barazl
Saml r Kha I i I Moussa
*VI ctor Moun I r Zabaneh
Youssef Soliman Fadel
Lucy Ayoub E I Maraghy+
Madiha Andre Khayyat
Mehry Kassem Mourad
Mervat Hakkl+
Zahlra Ahmed Saidan
Zakia Ishak Darwish+
From the Graduate Faculty
SO~IO STATE SCIENCE
Ahmed Oia Eldin Aly Hussein
Claude Emile Haghrabi
MASTER OF ARTS
Mohgah Farid Houstafa
HoustafaMahmoud Mansour
From the Graduate Faculty
ARABIC STUDIES
Mohamad Gams I Uddi n Ayyad
Nadia Roweis Farag
Sam I r Wahb
Indeterminate and Erroneous Fine-Needle Aspirates of Breast with Focus on the 'True Gray Zone': A Review
No full textObjective: To review our experience and the literature on inconclusive-erroneous fine-needle aspirates (FNAs) of breast with the focus on the 'true gray zone'. To describe the cytology, differential diagnosis, pitfalls and limitations of common and rare lesions. Study Design: We conducted a literature search focusing on breast FNAs with statistical data of C3 and C4 categories including false-positive and false-negative cases. Similar data from 2003 to 2009 was obtained from our institution. Results: C3 and C4 categories account for 3-17percent of breast FNAs. Contributing factors are technical difficulties, inexperienced pathologists interpreting FNAs of breast and overlap of cytologic features of certain benign and malignant conditions; this last, 'true gray zone' accounts for 2percent of cases. Fibroadenoma, proliferative breast lesions, gynecomastia, infiltrating and in situ low-grade adenocarcinomas and tubular, cribriform, lobular and mucinous carcinomas are the most common problematic lesions. Granular cell tumor, adenomyoepithelioma, pregnancy-related lesions, fat necrosis, inflammatory and radiation changes, adenoid cystic carcinoma, spindle-cell lesions and Phyllodes tumor are less common. Conclusion: Inconclusive-erroneous FNAs of breast due to the 'true gray zone' are rare. Most are due to the overlapping cytologic features of some benign and malignant conditions. Practical features that may help arrive at the correct diagnoses are elucidated. Copyright © 2013 S. Karger AG, Basel.Abd el-All Howayda S, 2006, Diagn Pathol, V1, P13, DOI 10.1186-1746-1596-1-13; ABENDROTH CS, 1991, AM J CLIN PATHOL, V96, P654; Adeniran Adebowale, 2004, Breast J, V10, P528, DOI 10.1111-j.1075-122X.2004.21525.x; ALKAISI N, 1994, ACTA CYTOL, V38, P898; Alvarez-Rodriguez F, 2012, ACTA CYTOL, V56, P501, DOI 10.1159-000341626; Amrikachi M, 2001, ACTA CYTOL, V45, P948; Abati A, 1997, DIAGN CYTOPATHOL, V16, P295; Aydin O, 2001, DIAGN CYTOPATHOL, V25, P194, DOI 10.1002-dc.2036; BARDALES RH, 1994, DIAGN CYTOPATHOL, V10, P336, DOI 10.1002-dc.2840100409; BENOIT JL, 1992, DIAGN CYTOPATHOL, V8, P643, DOI 10.1002-dc.2840080623; Bhattarai S, 2000, ACTA CYTOL, V44, P790; Bibbo M, 2008, COMPREHENSIVE CYTOPA, P715; BIBBO M, 1988, ACTA CYTOL, V32, P193; BONDESON L, 1990, ACTA CYTOL, V34, P15; Bonzanini M, 1997, DIAGN CYTOPATHOL, V17, P353, DOI 10.1002-(SICI)1097-0339(199711)17:5353::AID-DC83.0.CO;2-B; Cai GP, 2004, DIAGN CYTOPATHOL, V30, P396, DOI 10.1002-dc.20069; Cangiarella J, 2003, ACTA CYTOL, V47, P965, DOI 10.1159-000326669; Cangiarella J, 2001, DIAGN CYTOPATHOL, V25, P311, DOI 10.1002-dc.2161; Chaiwun B., 2005, SMJ Singapore Medical Journal, V46, P706; Chang A, 2002, DIAGN CYTOPATHOL, V26, P191, DOI 10.1002-dc.10073; Chhieng DC, 1999, CANCER CYTOPATHOL, V87, P359, DOI 10.1002-(SICI)1097-0142(19991225)87:6359::AID-CNCR73.0.CO;2-7; Cho EY, 2001, ACTA CYTOL, V45, P353; Choi YD, 2004, ACTA CYTOL, V48, P801, DOI 10.1159-000326449; Choudhury M, 2001, Indian J Pathol Microbiol, V44, P445; Davis WG, 2005, AM J SURG PATHOL, V29, P1456, DOI 10.1097-01.pas.0000176431.96326.49; Deb RA, 2001, CYTOPATHOLOGY, V12, P219, DOI 10.1046-j.1365-2303.2001.00332.x; Dei Tos Angelo P., 1994, Diagnostic Cytopathology, V11, P146; DELATORRE M, 1994, ACTA CYTOL, V38, P884; DeMay R M, 1984, Pathol Annu, V19 Pt 2, P121; DORNFELD JM, 1992, DIAGN CYTOPATHOL, V8, P79, DOI 10.1002-dc.2840080117; DUANE GB, 1987, ACTA CYTOL, V31, P742; DUSENBERY D, 1992, ACTA CYTOL, V36, P215; Eckert R, 1999, DIAGN CYTOPATHOL, V21, P105, DOI 10.1002-(SICI)1097-0339(199908)21:2105::AID-DC53.0.CO;2-G; FARMER C, 1995, DIAGN CYTOPATHOL, V12, P51, DOI 10.1002-dc.2840120112; Feichter GE, 1997, ACTA CYTOL, V41, P327; Field A, 2007, DIAGN CYTOPATHOL, V35, P386, DOI 10.1002-dc.20652; FILOMENA CA, 1992, DIAGN CYTOPATHOL, V8, P327, DOI 10.1002-dc.2840080404; FISHER CJ, 1992, HISTOPATHOLOGY, V21, P69; Garijo MF, 2008, PATHOL INT, V58, P787, DOI 10.1111-j.1440-1827.2008.02312.x; Gobbi H, 2000, AM J CLIN PATHOL, V113, P288; GREENBERG ML, 1994, DIAGN CYTOPATHOL, V11, P188, DOI 10.1002-dc.2840110216; Greenberg ML, 1997, DIAGN CYTOPATHOL, V16, P537, DOI 10.1002-(SICI)1097-0339(199706)16:6537::AID-DC133.3.CO;2-C; GRENKO RT, 1990, ACTA CYTOL, V34, P21; Gupta D, 1999, ACTA CYTOL, V43, P191; Gupta RK, 2010, ACTA CYTOL, V54, P138, DOI 10.1159-000324998; Gupta RK, 1997, ACTA CYTOL, V41, P1139; Gupta RK, 1999, DIAGN CYTOPATHOL, V20, P82, DOI 10.1002-(SICI)1097-0339(199902)20:282::AID-DC83.0.CO;2-0; GUPTA RK, 1993, DIAGN CYTOPATHOL, V9, P156, DOI 10.1002-dc.2840090209; Haji BE, 2007, DIAGN CYTOPATHOL, V35, P408, DOI 10.1002-dc.20661; Harada O, 2011, J CLIN PATHOL, V64, P776, DOI 10.1136-jclinpath-2011-200094; Howell LP, 1999, DIAGN CYTOPATHOL, V21, P217, DOI 10.1002-(SICI)1097-0339(199909)21:3217::AID-DC153.0.CO;2-7; INGRAM DL, 1984, ARCH PATHOL LAB MED, V108, P897; Ishihara A, 2006, DIAGN CYTOPATHOL, V34, P373, DOI 10.1002-dc.20445; Ishikawa Takashi, 2007, Breast Cancer, V14, P388, DOI 10.2325-jbcs.14.388; Iwa N, 2009, DIAGN CYTOPATHOL, V37, P143, DOI 10.1002-dc.20911; Iyengar P, 2006, CANCER CYTOPATHOL, V108, P250, DOI 10.1002-cncr.21839; Jamal AA, 2001, SAUDI MED J, V22, P67; Jayaram G, 2007, ACTA CYTOL, V51, P3, DOI 10.1159-000325674; Kanhoush R, 2004, CANCER CYTOPATHOL, V102, P164, DOI 10.1002-cncr.20283; Kapila K, 2002, CYTOPATHOLOGY, V13, P300, DOI 10.1046-j.1365-2303.2002.00423.x; Kasagawa Takahiro, 2006, Breast Cancer, V13, P112, DOI 10.2325-jbcs.13.112; Khirwadkar N, 2005, ACTA CYTOL, V49, P344; KLINE TS, 1981, ACTA CYTOL, V25, P263; Klopcic U, 2009, ACTA CYTOL, V53, P109, DOI 10.1159-000325095; Kollur SM, 2006, CYTOPATHOLOGY, V17, P239, DOI 10.1111-j.1365-2303.2006.00360.x; Krishnamurthy S, 2000, CANCER CYTOPATHOL, V90, P342, DOI 10.1002-1097-0142(20001225)90:6342::AID-CNCR43.0.CO;2-I; Kundu UR, 2012, AM J CLIN PATHOL, V138, P96, DOI 10.1309-AJCP8MN5GXFZULRD; Kurashina M, 2002, DIAGN CYTOPATHOL, V26, P29, DOI 10.1002-dc.10037; Laforga JBM, 1998, DIAGN CYTOPATHOL, V19, P55, DOI 10.1002-(SICI)1097-0339(199807)19:155::AID-DC113.0.CO;2-7; LAMB J, 1994, CYTOPATHOLOGY, V5, P17, DOI 10.1111-j.1365-2303.1994.tb00123.x; Landeyro J, 2012, DIAGN CYTOPATHOL, V40, P1107, DOI 10.1002-dc.21720; Layfield LJ, 1996, DIAGN CYTOPATHOL, V15, P250, DOI 10.1002-(SICI)1097-0339(199609)15:3250::AID-DC153.0.CO;2-F; Lee WY, 2000, ACTA CYTOL, V44, P488; LILLENG R, 1992, ACTA CYTOL, V36, P48; Lopez-Ferrer P, 1999, ACTA CYTOL, V43, P579; Lui PCW, 2007, J CLIN PATHOL, V60, P529, DOI 10.1136-jcp.2006.039412; Magro G, 2008, ARCH PATHOL LAB MED, V132, P1813, DOI 10.1043-1543-2165-132.11.1813; Mak A, 2006, DIAGN CYTOPATHOL, V34, P818, DOI 10.1002-dc.20560; Martin-Bates E, 1990, Cytopathology, V1, P79, DOI 10.1111-j.1365-2303.1990.tb00332.x; MartinezParra D, 1997, DIAGN CYTOPATHOL, V17, P108, DOI 10.1002-(SICI)1097-0339(199708)17:2108::AID-DC53.0.CO;2-C; McKee GT, 1999, CANCER CYTOPATHOL, V87, P203, DOI 10.1002-(SICI)1097-0142(19990825)87:4203::AID-CNCR73.3.CO;2-5; Mehrotra Ravi, 2004, Indian J Pathol Microbiol, V47, P377; Mercado CL, 2007, DIAGN CYTOPATHOL, V35, P690, DOI 10.1002-dc.20722; Michael CW, 2002, CANCER CYTOPATHOL, V96, P92, DOI 10.1002-cncr.10481; Mitre BK, 1997, ACTA CYTOL, V41, P1121; Mooney EE, 1998, DIAGN CYTOPATHOL, V19, P317, DOI 10.1002-(SICI)1097-0339(199810)19:4317::AID-DC203.0.CO;2-P; Ng WK, 2002, ACTA CYTOL, V46, P317, DOI 10.1159-000326728; Ng WK, 2001, ACTA CYTOL, V45, P593; Nggada H A, 2007, Afr J Med Med Sci, V36, P295; NIEMANN TH, 1995, DIAGN CYTOPATHOL, V12, P245, DOI 10.1002-dc.2840120311; NILSSON B, 1994, ACTA CYTOL, V38, P431; Nogueira M, 1998, CYTOPATHOLOGY, V9, P291, DOI 10.1046-j.1365-2303.1998.00118.x; NOVOTNY DB, 1991, ACTA CYTOL, V35, P676; ONeil S, 1997, SURGERY, V122, P824, DOI 10.1016-S0039-6060(97)90093-3; PETERSE JL, 1989, SEMIN DIAGN PATHOL, V6, P126; PETERSE JL, 1989, ACTA CYTOL, V33, P176; PHILLIPSON J, 1994, ACTA CYTOL, V38, P479; PINEDO F, 1991, ACTA CYTOL, V35, P229; Poniecka AW, 2001, ACTA CYTOL, V45, P797; RO JY, 1991, ARCH PATHOL LAB MED, V115, P137; ROGERS LA, 1992, AM J CLIN PATHOL, V98, P155; Rosa M, 2012, DIAGN CYTOPATHOL, V40, P26, DOI 10.1002-dc.21497; Rosa M, 2012, DIAGN CYTOPATHOL, V40, P179, DOI 10.1002-dc.21601; RUSSIN VL, 1989, DIAGN CYTOPATHOL, V5, P243, DOI 10.1002-dc.2840050303; Saad RS, 2012, DIAGN CYTOPATHOL, V40, P1005, DOI 10.1002-dc.21705; Saqi A, 2004, DIAGN CYTOPATHOL, V30, P271, DOI 10.1002-dc.20015; Sauer T, 2005, CANCER CYTOPATHOL, V105, P21, DOI 10.1002-cncr.20735; Shabb NS, 1997, ACTA CYTOL, V41, P321; Sidawy M, 2007, VOLUME SERIES FDN DI; Sidawy MK, 1998, DIAGN CYTOPATHOL, V18, P150, DOI 10.1002-(SICI)1097-0339(199802)18:2150::AID-DC123.0.CO;2-K; Siddiqui MT, 2002, DIAGN CYTOPATHOL, V26, P87, DOI 10.1002-dc-10066; SILVERMAN JF, 1993, DIAGN CYTOPATHOL, V9, P713, DOI 10.1002-dc.2840090623; Simsir A, 2003, CANCER CYTOPATHOL, V99, P156, DOI 10.1002-cncr.11062; Simsir A, 2012, DIAGN CYTOPATHOL, V40, P262, DOI 10.1002-dc.21630; Simsir A, 2009, DIAGN CYTOPATHOL, V37, P140, DOI 10.1002-dc.20987; Simsir A, 2001, DIAGN CYTOPATHOL, V25, P278, DOI 10.1002-dc.2055; Singh R, 2012, DIAGN CYTOPATHOL, V40, P113, DOI 10.1002-dc.21507; SNEIGE N, 1993, DIAGN CYTOPATHOL, V9, P106, DOI 10.1002-dc.2840090122; SNEIGE N, 1994, HUM PATHOL, V25, P485, DOI 10.1016-0046-8177(94)90120-1; STANLEY MW, 1989, DIAGN CYTOPATHOL, V5, P134, DOI 10.1002-dc.2840050205; STANLEY MW, 1993, DIAGN CYTOPATHOL, V9, P184, DOI 10.1002-dc.2840090215; STANLEY MW, 1990, DIAGN CYTOPATHOL, V6, P375, DOI 10.1002-dc.2840060602; STROBEL SL, 1985, ACTA CYTOL, V29, P598; THOMAS PA, 1994, DIAGN CYTOPATHOL, V11, P301, DOI 10.1002-dc.2840110321; VALENTE PT, 1994, DIAGN CYTOPATHOL, V10, P165, DOI 10.1002-dc.2840100215; Vicandi B, 2004, CYTOPATHOLOGY, V15, P321, DOI 10.1111-j.1365-2303.2004.00166.x; WEAVER MG, 1993, PATHOL RES PRACT, V189, P873; Westenend PJ, 2002, CANCER CYTOPATHOL, V96, P101, DOI 10.1002-cncr.10483; WILLIS SL, 1995, ACTA CYTOL, V39, P8580
Prevalence of overweight and obesity in adults from North Africa
No full textThe share of North African immigrants in Europe is growing continuously. In this review, we aimed to systematically analyse and describe the literature on weight status and physical activity in North African adults, both in their home country and after immigration to Europe. Existing data on North African residents and on North African immigrants in Europe were analysed by a systematic search on PUBMED. There is a wide variation among countries in the prevalence of overweight/obesity, with immigrants showing higher values. The overall results revealed a higher prevalence of overweight and obesity in females than in males in North African residents. Females also show higher levels of obesity among immigrants. In particular, literature reports indicate that 1.3-47.8% of North African residents and 3.6-49.4% of North African immigrants in adult age are overweight or obese. Physical inactivity is higher than 20% in males and 40% in females in North African residents. The highest frequency of physically inactive or lightly active people among immigrants was observed in first-generation Sudanese and Moroccans in Amsterdam (males: 57.1%; females: 74.2%), with increasing rates in second-generation females. The results underline a higher health risk in North African immigrants than in residents. Specific public health strategies should be adopted in various populations of North African origin to control the obesity epidemic.The share of North African immigrants in Europe is growing continuously. In this review, we aimed to systematically analyse and describe the literature on weight status and physical activity in North African adults, both in their home country and after immigration to Europe. Existing data on North African residents and on North African immigrants in Europe were analysed by a systematic search on PUBMED. There is a wide variation among countries in the prevalence of overweight/obesity, with immigrants showing higher values. The overall results revealed a higher prevalence of overweight and obesity in females than in males in North African residents. Females also show higher levels of obesity among immigrants. In particular, literature reports indicate that 1.3-47.8% of North African residents and 3.6-49.4% of North African immigrants in adult age are overweight or obese. Physical inactivity is higher than 20% in males and 40% in females in North African residents. The highest frequency of physically inactive or lightly active people among immigrants was observed in first-generation Sudanese and Moroccans in Amsterdam (males: 57.1%; females: 74.2%), with increasing rates in second-generation females. The results underline a higher health risk in North African immigrants than in residents. Specific public health strategies should be adopted in various populations of North African origin to control the obesity epidemic. © 2014 The Author 2014. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved
- …
